Not yet recruitingNCT05664035

SPAD in Adult Patients

Studying Immunodeficiency due to selective anti-polysaccharide antibody deficiency

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University Hospital, Lille
Principal Investigator: Guillaume LEFEVRE, MD,PhD
University Hospital, Lille
Intervention: Diagnosis of SPAD using immunization with PPV23(biological)
Enrollment: 99 target
Eligibility: 18-65 years · All sexes
Timeline: 2023 – 2026

Collaborators

French Healthcare network for rare immune and hematological disorders (MARIH) · Takeda · VitalAire · Laboratoire français de Fractionnement et de Biotechnologies

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05664035 on ClinicalTrials.gov

← Back to all trials